Published in Neoplasma on January 01, 1977
Interferon-specific effects on protein synthesis in P3HR-1 cells. EMBO J (1982) 0.79
Carcinogenesis by RNA sarcoma viruses. XII. A quantitative study of infection of rat cells in vitro by avian sarcoma viruses. Virology (1970) 3.90
Isolation and characterization of a 2.3-kilobase-pair cDNA fragment encoding the binding domain of the bovine leukemia virus cell receptor. J Virol (1993) 1.58
Cancer stem cells. Neoplasma (2005) 1.40
Importance of localized skin infection in tick-borne encephalitis virus transmission. Virology (1996) 1.30
In vitro analysis of cisplatin functionalized magnetic nanoparticles in combined cancer chemotherapy and electromagnetic hyperthermia. IEEE Trans Nanobioscience (2008) 1.05
Virus production in rat tumors induced by chicken sarcoma virus. J Natl Cancer Inst (1966) 0.96
Modifications of hybridoma technology which improve the yield of monoclonal antibody producing cells. J Immunol Methods (1988) 0.95
In vivo heating of magnetic nanoparticles in alternating magnetic field. Med Phys (2004) 0.93
AC-magnetic field controlled drug release from magnetoliposomes: design of a method for site-specific chemotherapy. Bioelectrochemistry (2002) 0.92
Induction of immune deficiency syndrome in rabbits by bovine leukaemia virus. AIDS (1989) 0.92
Infection of rats with bovine leukaemia virus: establishment of a virus-producing rat cell line. J Gen Virol (1989) 0.92
In vivo study of genetically simplified bovine leukemia virus derivatives that lack tax and rex. J Virol (1997) 0.92
Anti-interleukin-8 activity of tick salivary gland extracts. Parasite Immunol (2001) 0.92
Inhibition of the antiviral action of interferon by tick salivary gland extract. Parasite Immunol (2000) 0.88
Salivary gland extracts of partially fed Dermacentor reticulatus ticks decrease natural killer cell activity in vitro. Immunology (1994) 0.88
Mapping of sequential epitopes recognized by monoclonal antibodies on the bovine leukaemia virus external glycoproteins expressed in Escherichia coli by means of antipeptide antibodies. J Gen Virol (1992) 0.87
Isolation and characterization of cell clones producing various amounts of bovine leukosis virus. Folia Biol (Praha) (1985) 0.87
Novel germline mutation in the transmembrane region of RET gene close to Cys634Ser mutation associated with MEN 2A syndrome. J Mol Med (Berl) (2004) 0.86
Heterogeneity in the effect of different ixodid tick species on human natural killer cell activity. Parasite Immunol (2002) 0.86
Monoclonal antibodies neutralizing human leukocyte acid- and thermolabile interferon alpha. Acta Virol (1989) 0.86
An interferon like substance induced by mannans. Acta Virol (1967) 0.85
Isolation of the missing 5'-end of the encoding region of the bovine leukemia virus cell receptor gene. Arch Virol (1994) 0.84
Genotoxic damage of human adipose-tissue derived mesenchymal stem cells triggers their terminal differentiation. Neoplasma (2009) 0.84
Tick salivary gland extracts promote virus growth in vitro. Parasitology (1998) 0.83
Double-stranded f 2 phage RNA as interferon inducer. Acta Virol (1971) 0.82
The effect of postfusion cell density on establishment of hybridomas. Folia Biol (Praha) (1988) 0.82
Electrophoretic profiles and activities of human interferon in heterologous cells. Intervirology (1974) 0.81
Use of monoclonal antibodies in an ELISA for the diagnosis of bovine leukaemia virus infection. J Virol Methods (1990) 0.81
Enhancing effect of anti-endotoxic serum on interferon induction in mouse peritoneal cells by endotoxin. Acta Virol (1968) 0.81
Bovine leukemia virus structural gene vectors are immunogenic and lack pathogenicity in a rabbit model. J Virol (1999) 0.81
Enhancement of neutralizing efficacy by combining three monoclonal antibodies to human interferon-alpha. Immunology (1991) 0.81
Site-specific in vivo targeting of magnetoliposomes using externally applied magnetic field. Z Naturforsch C (2000) 0.81
Prevention of spontaneous autoimmunity to DNA in NZB/Swiss mice by treatment with natural double-stranded RNA. Immunology (1975) 0.81
Release of interferon by mouse peritoneal cells in vitro. The requirement of contact with endotoxin and the temperature dependence of release. Acta Virol (1969) 0.81
Induction of leukemia in chicken by bovine leukemia virus due to insertional mutagenesis. Arch Geschwulstforsch (1990) 0.80
Treatment of human tumor cells by combine gene therapy harnessing plasmids expressing human tumor necrosis factor alpha and bacterial cytosine deaminase suicide gene. Neoplasma (2006) 0.80
Activation of NK cells in subjects exposed to mild hyper- or hypothermic load. J Interferon Res (1988) 0.79
Polyclonal bovine sera but not virus-neutralizing monoclonal antibodies block bovine leukemia virus (BLV) gp51 binding to recombinant BLV receptor BLVRcp1. J Virol (1997) 0.79
Early diagnosis of virus induced bovine leukosis in milk by a simple modified ELISA test. Zentralbl Veterinarmed B (1982) 0.79
Two immunodominant regions revealed by monoclonal antibodies on the main structural protein p24 of bovine leukemia virus. Viral Immunol (1993) 0.79
Periodicity of interferon appearance in serum of patients with systemic lupus erythematosus. Arthritis Rheum (1984) 0.78
Preparation and characterization of hybridomas producing monoclonal antibodies against human alpha interferon. Acta Virol (1986) 0.78
Human glioma cells expressing herpes simplex virus thymidine kinase gene treated with acyclovir, ganciclovir and bromovinyldeoxyuridine. Evaluation of their activity in vitro and in nude mice. Neoplasma (2001) 0.78
The reticuloendothelial system and virus infection. II. Production of interferon- and antibody-like substances in mouse peritoneal cells infected with myxoviruses in vivo. Arch Gesamte Virusforsch (1965) 0.78
Interferon as therapeutic agent. Acta Virol (1983) 0.78
Antiviral and cell-growth inhibitory activities of highly purified L-cell interferon. An analysis of quantitative disproportions. Acta Virol (1975) 0.78
The temperature requirement for interferon production in cells stimulated by Newcastle disease virus or microbial agents in vitro. Acta Virol (1967) 0.78
Interferon alpha2b is the predominant subvariant detected in human genomic DNAs. Acta Virol (1994) 0.78
Activation of the complement system by interferon inducers. Acta Virol (1972) 0.78
Promotion of vesicular stomatitis virus nucleocapsid protein production by arthopod saliva. Acta Virol (1999) 0.78
Preparation and characterization of monoclonal antibodies directed against glycoproteins of bovine leukaemia virus. Acta Virol (1993) 0.78
Distribution of antiviral and cell-inhibitory activity in interferon preparations. Acta Virol (1972) 0.77
Cross-species antiviral and antiproliferative activity of human interferon-omega. J Interferon Res (1994) 0.77
Transformation of rat liver cells with chicken sarcoma virus B77 and murine sarcoma virus. J Virol (1973) 0.77
Are the acid-labile interferon alpha and interferon omega-1 identical? Virology (1991) 0.77
Current view on the perspectives of interferon therapy. Acta Virol (1986) 0.77
Therapeutic use of double-stranded RNAs in man. Tex Rep Biol Med (1983) 0.77
Presence of serum carbonic anhydrase autoantibodies in patients relapsed after autologous stem cell transplantation indicates an improved prognosis. Neoplasma (2008) 0.77
Comparison of manganese superoxide dismutase precursor induction ability in human hepatoma cells with or without hepatitis B virus DNA insertion. Acta Virol (2000) 0.77
Affinity chromatography of mouse interferon: a modified purification procedure utilizing specifically purified antibodies. Acta Virol (1976) 0.77
The human homologue of the bovine leukemia virus receptor BLVRcp1 is the delta-subunit of adaptor-related AP-3 protein that does not bind the BVLgp51. Arch Virol (1999) 0.76
Interferon alpha-induced modulation of leukocyte cell surface antigens: immunocytofluorometric study with human leukaemia/lymphoma cell lines. Acta Virol (1991) 0.76
Abnormal macrophages and NK cell cytotoxicity in human systemic lupus erythematosus and the role of interferon and serum factors. Acta Virol (1989) 0.76
Immunodominant structures in the aminoterminal portion of human interferon alpha 1. Mol Immunol (1992) 0.76
[N[2-hydroxyethyl] palmitamide repeated administration effect on interferon production in mouse organism after phage double-stranded ribonucleic acid [ds-RNA] application (author's transl)]. Cesk Epidemiol Mikrobiol Imunol (1978) 0.76
Peptide-mapping of three neutralizing epitopes into predicted biologically active sites of human interferon-alpha 2. Immunol Lett (1993) 0.76
Effect of impulsin treatment of interferon production and antiviral resistance of mice. Arch Immunol Ther Exp (Warsz) (1977) 0.76
Dental pulp mesenchymal stem/stromal cells labeled with iron sucrose release exosomes and cells applied intra-nasally migrate to intracerebral glioblastoma. Neoplasma (2016) 0.75
Vesicular stomatitis virus nucleocapsid protein production in cells treated with selected fast protein liquid chromatography fractions of tick salivary gland extracts. Acta Virol (2002) 0.75
Cell-derived vaccine against bovine leukaemia virus infection. Zentralbl Veterinarmed B (1988) 0.75
Use of bacteriophage nucleic acid inducers of interferon in man. Tex Rep Biol Med (1977) 0.75
Interactions between viral infection and immune mechanisms. Comp Immunol Microbiol Infect Dis (1980) 0.75
The cell growth inhibitory and antiviral effects of interferon in cloned transformed mouse cells. Ann N Y Acad Sci (1980) 0.75
Distinct effect of pH 2 on a common antigenic structure found in human interferons-alpha 1 and -alpha 2 in the region 30-35. J Interferon Res (1991) 0.75
[Peritoneal macrophages and interferon formation (author's transl)]. Cesk Epidemiol Mikrobiol Imunol (1974) 0.75
[Double-fiber ribonucleic acid in the treatment of viral dermatoses]. Cesk Dermatol (1973) 0.75
Interferon-hyporesponsiveness in mice in connection with dose interval and site of administration of Newcastle disease virus. Reflexion in serum complement levels. Acta Virol (1975) 0.75
Contribution to the problem of purity of interferon preparations. Acta Virol (1973) 0.75
Decrease of sensitivity to cell-growth inhibitory effect of interferon in human embryo cells after infection with SV40. Acta Virol (1979) 0.75
Production of interferon and other lymphokines during murine tumour growth. II. Induction of an interferon by Ehrlich ascites cells in outbred mice. Acta Virol (1980) 0.75
Release of an interferon-like virus inhibitor during contact of mouse leukocytes with target cells. Acta Virol (1970) 0.75
The effect of interferon induction on complement level in rat. Acta Biol Med Ger (1979) 0.75
Quantitative immunoelectrophoresis of human interferon. A new approach to characterization of interferon preparations. Acta Virol (1978) 0.75
Antiviral and cell-growth inhibitory effect of interferon. Biomedicine (1973) 0.75
Production of antiviral and migration inhibitory activities in the peritoneum of mice after inoculation with allogenic Ehrlich ascites tumor cells. Acta Biol Med Ger (1979) 0.75
The effect of native and sonicated double-stranded polyribonucleotides on the course of spontaneous autoimmune disease in NZB and NZB/Swiss F1 mice. Acta Virol (1979) 0.75
Patterns of interferon induction in leuckocytes. Acta Microbiol Pol A (1973) 0.75
Production of interferon and other lymphokines during murine tumour growth. I. Lymphokines in cell--free fluid of rat Zajdela ascites hepatoma. Acta Virol (1980) 0.75
Long-term culture of guinea pig tongue cells: a suitable interferon system. Acta Virol (1979) 0.75
Effect of different polyribonucleotides on the induction of antibodies to DNA and RNA and serum complement level in mice. Acta Biol Med Ger (1979) 0.75
Antiviral and anticellular effects of interferon on the mouse embryonic cells transformed by viruses and/or chemical carcinogen. Acta Biol Med Ger (1979) 0.75
Production of human leukocyte interferon for clinical use under immunoelectrophoretic control. Acta Biol Med Ger (1979) 0.75
[Double stranded RNA and a nonspecific stimulator of the organism's defense mechanism]. Bratisl Lek Listy (1978) 0.75
Some properties of interferon released by mouse peritoneal leukocytes stimulated with endotoxin, mannan and Newcastle disease virus in vitro. Acta Virol (1970) 0.75
Twenty years after discovery of interferon: the progress and the persistent problems. Acta Biol Med Ger (1979) 0.75